Funding for this research was provided by:
Florida Department of Health (22A17)
National Institute of Health (R56AG069676, R56AG064075, RF1AG071762, R21AG072379, U01AG076928)
Article History
Received: 11 January 2023
Accepted: 1 August 2023
First Online: 10 August 2023
Declarations
:
: None of the authors report any conflict of interest related to this work. HY is Co-founder and Chief Scientific Officer of Postbiotics Inc and SJ is founder of MusB LLC, but their roles have no conflict and influence with the work presented in this manuscript.